50th week of 2010 patent applcation highlights part 46 |
Patent application number | Title | Published |
20100317828 | IFBM'S TO PROMOTE THE SPECIFIC ATTACHMENT OF TARGET ANALYTES TO THE SURFACE OF ORTHOPEDIC IMPLANTS - The present invention provides an improved coating for surfaces of medical implants. The coating comprises at least one interfacial biomaterial (IFBM) which is comprised of at least one binding module that binds to the surface of an implant or implant-related material (“implant module”) and at least one binding module that selectively binds to a target analyte or that is designed to have a desired effect (“analyte module”). The modules are connected by a linker. In some embodiments, the IFBM coating acts to promote the recognition and attachment of target analytes to surface of the device. The IFBM coating improves the performance of implanted medical devices, for example, by promoting osteointegration of the implant. | 2010-12-16 |
20100317829 | IFBM'S TO PROMOTE THE SPECIFIC ATTACHMENT OF TARGET ANALYTES TO THE SURFACE OF ORTHOPEDIC IMPLANTS - The present invention provides an improved coating for surfaces of medical implants. The coating comprises at least one interfacial biomaterial (IFBM) which is comprised of at least one binding module that binds to the surface of an implant or implant-related material (“implant module”) and at least one binding module that selectively binds to a target analyte or that is designed to have a desired effect (“analyte module”). The modules are connected by a linker. In some embodiments, the IFBM coating acts to promote the recognition and attachment of target analytes to surface of the device. The IFBM coating improves the performance of implanted medical devices, for example, by promoting osteointegration of the implant. | 2010-12-16 |
20100317830 | BACE455, AN ALTERNATIVE SPLICE VARIANT OF THE HUMAN BETA-SECRETASE - The present invention relates generally to the fields of genetics, biochemistry, medicinal chemistry and medicine. The present invention more particularly discloses the identification of a human gene variant involved in neuropathological conditions, and methods for the diagnosis, prevention and treatment of such diseases and related disorders, as well as for the screening of therapeutically active drugs. The present invention relates to catalytically active beta-secretase (Memapsin2, BACE) variants, and nucleic acids encoding them. The invention is useful in the identification of agents that inhibit the activity of a particular BACE isoform and thus agents and therapies affecting the genesis, development or progression of neuropathological conditions, including Alzheimer's disease and dementia. | 2010-12-16 |
20100317831 | PROBE COMPOUNDS FOR PROTEIN TYROSINE PHOSPHATASE (PTP) AND PRECURSORS THEREOF - A probe compound for protein tyrosine phosphatases (PTPs), as shown in Formula (I) is provided. | 2010-12-16 |
20100317832 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION - The present invention applications for same. More particularly, the present invention relates to novel aziridine aldehydes and processes for preparing these novel compounds. The invention also relates to aziridine-conjugated amino derivatives, and processes for preparing the same. Pentacyclic compounds may be prepared using the aziridine aldehydes of the present invention, and the invention relates to these compounds and the processes by which they are made. The invention also relates to aziridine-conjugated bioactive molecules, such as amino acids and peptides, and processes for preparing such compounds. | 2010-12-16 |
20100317833 | METHOD FOR THE PRODUCTION OF DRY FREE-FLOWING HYDROPHOBIN PREPARATIONS - Method for the production of dry, free-flowing, stable hydrophobin preparations by spraying and drying aqueous hydrophobin solutions, if appropriate comprising additives in a spray device. | 2010-12-16 |
20100317834 | IgG Immunoglobulin Variants with Optimized Effector Function - The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes. | 2010-12-16 |
20100317835 | Anti-Adam-15 Antibodies and Utilization of the Same - A remedy for cancer obtained from a different viewpoint from the viewpoints employed in developing the existing anticancer drugs, i.e., focusing on the intercellular adhesion of cancer cells. Namely, provided is a remedy for cancer with fewer side effects which inhibits the proliferation of cancer cells and the intercellular adhesion of cancer cells. Also provided is an antibody, which recognizes the disintegrin domain of ADAM-15 and is usable as an anticancer agent, and so on. An antibody, which recognizes the disintegrin domain of ADAM-15 but does not recognize the RGD sequence or loop region in the disintegrin domain of ADAM-15, and so on; an antibody, which inhibits ADAM-15 and integrin αvβ3-dependent cell adhesion, and so on; and an antibody, which inhibits ADAM-15 and integrin αvβ1-dependent cell adhesion, and so on. | 2010-12-16 |
20100317836 | NOVEL BIOLOGICAL SUBSTANCE NESFATIN AND ITS RELATED SUBSTANCES AND USES THEREOF - The present invention relates to a novel method of obtaining a factor involved in appetite control and/or body weight control, as well as genes obtained by said method, polypeptides encoded by said genes, or novel polypeptides obtained from the information on polypeptides encoded by said genes as a means for treating, controlling or diagnosing diseases associated with eating disorders and/or body weight control. Also the present invention relates to substances that inhibit the effects of said genes or said polypeptides as a means for treating, controlling or diagnosing diseases associated with appetite control and/or body weight control. By using thiazolidine diones having a PPAR γ agonist activity, genes and polypeptides involved in appetite regulation and/or body weight reduction can be obtained. NESFATIN or the like obtained by said method can be used as a means for treating, controlling or diagnosing diseases associated with eating disorders and/or body weight control. | 2010-12-16 |
20100317837 | IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES - The present invention provides a method of identifying novel broadly crossreactive neutralizing monoclonal antibodies using sequential antigen panning of phage display libraries, antibodies obtained in accordance with such a method, as well as fusion proteins and conjugates comprising same, and related isolated or purified nucleic acid molecules, vectors, host cells, compositions, and methods of use to inhibit an infection, reduce the severity of an infection, treat an infection, and inhibit cancer. | 2010-12-16 |
20100317838 | CYCLIC CARBONYL MONOMERS FUNCTIONALIZED WITH CARBOHYDRATES, POLYMERS DERIVED THEREFROM, AND METHODS OF PREPARATION THEREOF - A cyclic carbonyl monomer has the formula (7): | 2010-12-16 |
20100317839 | TP EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF - The present invention discloses a TP expression-inhibiting compound and a TP expression-inhibiting siRNA sequence, wherein a siRNA sequence partially or completely complementary to the sequence of TP is used to inhibit TP expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment. | 2010-12-16 |
20100317840 | hnRNP K EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF - The present invention discloses an hnRNP K expression-inhibiting compound and a siRNA sequence thereof, wherein a siRNA sequence partially or completely complementary to the sequence of hnRNP K is used to inhibit hnRNP K expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment. | 2010-12-16 |
20100317841 | Polyelectrolyte-Coated Size-Exclusion Ion-Exchange Particles - A polyelectrolyte-coated particle, devices for using the particle, methods for using the particle for separating PCR reaction products and/or DNA sequencing reaction products, and compositions for coating the particle are provided. | 2010-12-16 |
20100317842 | Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry - The present application discloses methods for identifying inhibitors with high binding-affinity for the carbonic anhydrase-IX (CA-IX) enzyme using click chemistry and uses the candidates thereof as positron emission tomography (PET) imaging agents. | 2010-12-16 |
20100317843 | PROCESS FOR SEPARATING BIOMASS COMPONENTS - The present invention provides a process and System for Separation of biomass components into individual components such as cellulose, hemicellulose and lignin. The present invention provides a process for separating lignin in its native form. The cellulose obtained by the process of the present invention is highly reactive for saccharification. | 2010-12-16 |
20100317844 | METAL SALT OF CROSSLINKED CELLULOSE DERIVATIVE - The invention provides a metal salt of a crosslinked cellulose derivative represented by the following formula (I), wherein the degree of substitution of the hydroxyl group of glucose unit of the crosslinked cellulose derivative by a functional group a is 1 or more. | 2010-12-16 |
20100317845 | Sucrose of new confrontational polymorphs and manufacturing method thereof - A sucrose of a conformational polymorph and its manufacturing method are disclosed. The sucrose is a Form II sucrose having a melting point of 140-180° C., and furfuryl alcohol is added into a saturated sucrose solution by a reverse solution method, such that the saturated solution is recrystallized to form a new sucrose. The sucrose of this conformational polymorph has a melting point lower than the melting point of a general Form I sucrose, and the solubility of the Form II sucrose is different from the solubility of the Form I sucrose. Thus the Form II sucrose can be used as an excipient of medicines, sacrificial fiber blood vessel network structure for cell cultivations, or the manufacture of an optical interference wavy device. Since the hydrogen bonds in the molecular structure of the Form II sucrose and the Form I sucrose are different, the mechanoluminescence of the sucrose is affected. | 2010-12-16 |
20100317846 | Production Of L-Iduronate Containing Polysaccharides - A process for the production of polysaccharide (20) from disaccharide (10) and saccharide (21), wherein R | 2010-12-16 |
20100317847 | CRYSTALLINE FORM OF 4-(BETA-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-- BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS - The invention relates to a crystalline form of 4-(β-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments. | 2010-12-16 |
20100317848 | PROCESS FOR THE SYNTHESIS OF DERIVATIVES OF 3-AMINO-TETRAHYDROFURAN-3-CARBOXYLIC ACID AND USE THEREOF AS MEDICAMENTS - The present invention relates to a process for the manufacturing of substituted 3-amino-tetrahydrofuran-3-carboxylic acid amides of general formula (I) and their precursors in high optical purity to the precursors of the synthesis of substituted S-Amino-tetrahydrofuran-S-carboxylic acid amides of general formula (I) in high optical purity, and to the tautomers, enantiomers, diastereomers, mixtures and salts of substituted 3-amino-tetrahydrofuran-3-carboxylic acid amides of general formula (I) in high optical purity, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties. | 2010-12-16 |
20100317849 | Process For Producing Pure And Stable Form Of 2-Methyl-4-(4-Methyl-1-Piperazinyl) -10H-Thieno[2,3-B] [1,5] Benzodiazepine - Disclosed is an improved process for producing pure and thermally color stable crystalline Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine and product thereof. The process comprises of reacting 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine in conjunction with N-methylpiperazine acid salt, to produce 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine. Also disclosed is a process for obtaining the Polymorphic Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][l,5J benzodiazepine by crystallizing the crude 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine in a mixture of solvents. Further the invention also provides a new polymorph of Olanzapine, dihydrate Form Ji and process for its preparation and a new hydrate Form J | 2010-12-16 |
20100317850 | CONDENSED AMINODIHYDROTHIAZINE DERIVATIVE - Disclosed is a compound represented by General formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the compound or the pharmaceutically acceptable salt, which has an inhibitory activity of the production of Aβ or a BACE1-inhibiting activity, and is therefore useful as a prophylactic or therapeutic agent for Aβ-induced neurodegenerative diseases typified by Alzheimer-type dementia. Wherein the ring A represents a C | 2010-12-16 |
20100317851 | LUMINOPHORES - There is described novel organo-platinum luminophores comprising a complex of formula (I). The luminophores have application as the emissive component in organic light emitting diodes. | 2010-12-16 |
20100317852 | AMINO-CONTAINING VINYLSILANE COMPOUNDS AND MAKING METHOD - Vinylsilane compounds having a specific amino group, typically diethylaminopropyldimethylvinylsilane, N-methylpiperazinylpropyldimethylvinylsilane, and bistrimethylsilylaminopropyldimethylvinylsilane are novel and useful as a modifier for polymers. | 2010-12-16 |
20100317853 | NOVEL IMATINIB CAMSYLATE AND METHOD FOR PREPARING THEREOF - The present invention relates to a novel imatinib camsylate and a method for preparing the same. Imatinib camsylate according to the present invention has a faster absorption rate and higher absorption concentration in terms of pharmacokinetics, and further has excellent water solubility, as compared to commercially available imatinib mesylate. | 2010-12-16 |
20100317854 | NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES - The invention relates to compounds of formulae (II), (IV), and (VI) as shown below, | 2010-12-16 |
20100317855 | PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE (2S,3S,5S)-5-AMINO-2-N,N-DIBENZYLAMINO-3-HYDROXY-1,6-DIPHENYLHEXANE - The present invention relates to the purification of (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane (III) by making its crystalline acid addition salt, which can be used as such to produce Lopinavir/Ritonavir with high purity and yield. Formula III | 2010-12-16 |
20100317856 | PROCESS FOR THE PREPARATION OF R-SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention provides processes for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof. | 2010-12-16 |
20100317857 | PROCESS FOR PREPARING ANHYDROUS ARIPIRAZOLE TYPE I - Type I anhydrous aripiprazole is prepared by dissolving aripiprazole (or an acid salt thereof) in an alcoholic solvent, optionally containing water, at elevated temperature, adding seed crystals of Type 1 anhydrous aripiprazole to the solution, cooling the mixture, and isolating crystals aripiprazole and drying the isolated crystals to obtain low moisture Type 1 anhydrous aripiprazole. | 2010-12-16 |
20100317858 | METAL COORDINATION COMPOUND AND LIGHT-EMITTING MATERIAL CONTAINING THE SAME - To provide a light-emitting device that is capable of red-light-emitting with high luminance and high efficiency and that is excellent in endurance; and a metal coordination compound metal coordination compound having a partial structure represented by formula (1) that can be used in the light-emitting device, and that can also be used in applications, such as organic electroluminescent device materials, electrochemiluminescence (ECL) device materials, emission sensors, photosensitizers, displays, photographic materials, laser dyes, color filter dyes, optical communications, color conversion filters, backlights, illuminations, photosensitizing dyes, various light sources, and the like. | 2010-12-16 |
20100317859 | Process for the Preparation of Risedronate Sodium - Disclosed herein is an improved, commercially viable and industrially advantageous process for the preparation of risedronic acid or a pharmaceutically acceptable salt thereof, in high yield and purity. | 2010-12-16 |
20100317860 | CRYSTALLINE CINNAMIDE COMPOUNDS OR SALTS THEREOF - Disclosed are crystals of the compound represented by Formula (1), which has A□-production-reducing effects and is a prodrug of compounds effective in treating neural degenerative diseases of which A□ is the cause, for example, diseases such as Alzheimer's disease, Down syndrome, etc., and salts thereof or crystals of salts thereof. These are particularly useful as stock for pharmaceutical products. | 2010-12-16 |
20100317861 | Remove Amination of 6-Keto Normorphinans by Catalytic Hydrogen Transfer - The present invention provides processes for the stereoselective synthesis of 6-alpha-amino morphinans. In particular, the invention provides processes for the reductive amination of 6-keto normorphinans by catalytic transfer hydrogenation. | 2010-12-16 |
20100317862 | USE OF COMPOUNDS AS INHIBITORS FOR HELICOBACTER FLAVODOXIN - Use of the general formula compound (I), or any salt thereof, for preparation of a pharmaceutical compound for the treatment of infections illnesses, in particular for the treatment of | 2010-12-16 |
20100317863 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof - Compounds of Formula (I) | 2010-12-16 |
20100317864 | Preparation Method of Phenylcarboxamides - A preparation method of phenylcarboxamides of formula (I), the reaction scheme of which is as follows: | 2010-12-16 |
20100317865 | ENZYME AND RECEPTOR MODULATION - Covalent conjugates of an α,α-disubstituted glycine ester and a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid and the α,α-disubstituted glycine ester is conjugated to the modulator at a position remote from the binding interface between the inhibitor and the target enzyme or receptor pass into cells and the active acid hydrolysis product accumulates within the cells. | 2010-12-16 |
20100317866 | IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS - The present invention relates to phosphorus compounds containing imidazole groups, to optically active ligands prepared using them, to transition metal complexes which comprise such ligands, and to catalysts which comprise such transition metal complexes. The present invention further relates to the particular processes for preparing the phosphorus compounds, the optically active ligands, the transition metal complexes and the catalysts, and also to the use of the catalysts for organic transformation reactions. | 2010-12-16 |
20100317867 | NEW PROCESS FOR THE PREPARATION OF 2-IMINO-THIAZOLIDIN-4-ONE DERIVATIVES - The present invention relates to a new process for the preparation of 2-imino-thiazolidin-4-one compounds of the Formula (I) and (II) and to compounds of Formula (II) as such. The present compounds of Formula (II) can be used as intermediates in the preparation of thiazolidin-4-one derivatives of the General Formula (II), said derivatives being described in WO 2005/054215. These compounds of General Formula (II) are described in WO 2005/054215 to act as immunosuppressive agents. | 2010-12-16 |
20100317868 | METHOD OF PREPARING TAXANE DERIVATIVES AND INTERMEDIATES USED THEREIN - The present invention relates to a novel method of preparing a taxane derivative having an anti-tumor and anti-leukemia activity, and intermediates used therein. | 2010-12-16 |
20100317869 | IMMOBILIZED CYCLIC IMIDE CATALYST AND PROCESS FOR OXIDATION OF ORGANIC COMPOUNDS WITH THE SAME - To provide a solid catalyst containing a cyclic imide skeleton which is easily available and easily separable from reaction products and which is easily recovered and regenerated, and free from reaction inhibitory factors; and a process for oxidation of organic compounds with the solid catalyst. | 2010-12-16 |
20100317870 | ANTIMICROBIAL POLYMERS - The invention generally relates to novel polymers (SMAMPs) and their syntheses and use. The polymers exhibit promising properties of AMPs. In particularly, for example, a ring-opening metathesis polymerization (ROMP) platform was developed that allows syntheses of SMAMPs that employ a minimum number of norbornene-based building blocks and/or enable easy and independent variation of hydrophobic and hydrophilic groups in the monomer units and/or along the polymeric backbone to finetune and select desirable properties of the polymers. | 2010-12-16 |
20100317871 | METHOD FOR THE PREPARATION OF DARIFENACIN HYDROGEN BROMIDE - A method of preparing (3S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl}-α,α-diphenyl-3-pyrrolidine acetamide hydrogen bromide, wherein 3-(S)-(I-carbamoyl-1,1-diphenylmethyl)pyrrolidine or its salt with an organic acid is alkylated in the presence of an inorganic base with 5-(2-bromoethyl)-2,3-dihydrobenzofurane in a heterogeneous system of the solvents water and an organic solvent selected from C6 to C9 aliphatic, alicyclic or aromatic hydrocarbons, after separation of the two phases the crude darifenacin base is isolated, which is converted to the hydrobromide by addition of a C3 to C9 ketone or C3 to C9 alcohol and concentrated hydrobromic acid. | 2010-12-16 |
20100317872 | THERAPEUTIC COMPOUNDS - A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC | 2010-12-16 |
20100317873 | PREPARATION OF POLYMER-FREE R-(+)-ALPHA-LIPOIC ACID - R-α-Lipoic acid and its homologs are converted to their magnesium salts in the presence of a reduced form of the acid, dihydro-(+)-lipoic acid in the case of R-α-lipoic acid itself. The reduced form serves as a polymerization inhibitor, resulting in a Mg di-R-α-lipoate product of higher purity. The reduced acid retained in the product tends to convert to the starting acid, thereby avoiding the inclusion of an extraneous polymerization inhibitor in the product. | 2010-12-16 |
20100317874 | Peroxide Reduction In Functionalized Vegetable Oils - Disclosed is an oil composition wherein the oil contains measurable amounts of peroxide resulting from peroxidation, and also includes an effective amount of a peroxide-reducing phosphorous compound, preferably an alkyl/aryl substituted phosphite compound or phosphinic acid (H | 2010-12-16 |
20100317875 | PERFLUOROPOLYETHER GROUP-CONTAINING ACRYLATE COMPOUND - The present invention relates to a photo-curable perfluoropolyether group-containing acrylate compound represented by the following formula (1): | 2010-12-16 |
20100317876 | TERRYLENE AND QUATERRYLENE DERIVATIVES - Rylene derivatives of the general formula I | 2010-12-16 |
20100317877 | ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES - New chemiluminescent compounds, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and 1,2-dioxetanes. Among the new acridane-based compounds are water-soluble acridanes, enhancer coupled acridanes, bis and tris-acridanes as well as acridane-1,2-dioxetanes. Among the new 1,2-dioxetanes are electron deficient group-containing dioxetanes and tethered bis-1,2-dioxetanes. The 1,2-dioxetanes are useful as substrates for various enzymes. The acridanes can be admixed with an oxidizing agent. an aqueous buffer and, optionally, a stabilizer to form a substrate or reagent formulation useful for assaying, inter alia, HRP. | 2010-12-16 |
20100317878 | PROCESS FOR PRODUCTION OF FLAKE-LIKE DRIED 2-(5-ETHYL-5-HYDROXYMETHYL-1,3-DIOXAN-2-YL)-2-METHYLPROPAN-1-OL - A method for producing flake-like dried DOG by making DOG containing from 10 to 50% by mass of a liquid go through a continuous melt-drying step of a specified condition and then making it go through, as a next step, a vacuum-drying step of a specified condition or a ventilation-drying step of a specified condition while holding a molten state thereof, to obtain DOG in which the liquid in DOG is reduced to not more than 0.5% by mass (dried DOG), and flaking the obtained dried DOG in a flake production step. | 2010-12-16 |
20100317879 | METHODS FOR CONVERSION OF CARBOHYDRATES IN IONIC LIQUIDS TO VALUE-ADDED CHEMICALS - Methods are described for converting carbohydrates including, e.g., monosaccharides, disaccharides, and polysaccharides in ionic liquids to value-added chemicals including furans, useful as chemical intermediates and/or feedstocks. Fructose is converted to 5-hydroxylmethylfurfural (HMF) in the presence of metal halide and acid catalysts. Glucose is effectively converted to HMF in the presence of chromium chloride catalysts. Yields of up to about 70% are achieved with low levels of impurities such as levulinic acid. | 2010-12-16 |
20100317880 | Direct epoxidation process using modifiers - The invention is a process for epoxidizing an olefin with hydrogen and oxygen in a solvent comprising tertiary butyl alcohol or acetonitrile in the presence of an amide modifier and a catalyst comprising titanium-MWW zeolite and a noble metal. The process produces less ring-opened products such as glycols and glycol ethers when performed in the presence of the amide, while maintaining low alkane byproduct formed by the hydrogenation of olefin. | 2010-12-16 |
20100317881 | PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS - Novel synthetic routes, which are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids are disclosed. Particularly, novel methods for efficiently preparing compounds having a glycerolic backbone and one or more oxidized moieties attached to the glycerolic backbone, which are devoid of column chromatography are disclosed. Further disclosed are novel methods of introducing phosphorous-containing moieties such as phosphate moieties to compounds having glycerolic backbone and intermediates formed thereby. | 2010-12-16 |
20100317882 | LONG CHAIN OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACID BIOSYNTHESIS BY EXPRESSION OF ACYL-CoA LYSOPHOSPHOLIPID ACYLTRANSFERASES - Methods for increasing C | 2010-12-16 |
20100317883 | MICROPROTEIN-INACTIVATING ULTRAFINE METAL PARTICLES - Microprotein-inactivating ultrafine metal particles comprising ultrafine metal particles having a bond between an organic acid component and a metal, having an infrared absorption peak ascribable to the bond between the organic acid and the metal near 1518 cm | 2010-12-16 |
20100317884 | POLYMERIZABLE SULFONATE IONIC LIQUIDS AND LIQUID POLYMERS THEREFROM - Disclosed is a new ionic liquid monomer salt and methods of is synthesis and polymerization. The ionic liquid monomer salt is prepared by mixing equimolar amounts of an amine, such as tris[2-(2-methoxyethoxy)-ethyl]amine and an acid functionalized polymerizable monomer, such as 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS), which is stirred at ambient temperature until salt formation is complete. Also disclosed is a new ionic liquid polymer salts and method for making the same. The synthesis of AMPS-ammonium salt polymer is accomplished by adding 2,2′-azobisisobutyronitrile (AIBN) to the ionic liquid monomer salt and heating the homogeneous melt at 70° C. for 18 hr. | 2010-12-16 |
20100317885 | Process For The Preparation Of Haloalkylalkoxysilanes And Haloalkylhalosilanes - This invention involves a process for the preparation of haloalkylalkoxysilanes and haloalkylhalosilancs. The process comprises reacting an alkoxyhydridosilane or a halohydridosilanc silane with an alkenylhalide compound in the presence of a catalytic amount of an iridium containing catalyst. When a halohydridosilane is the silane reactant. the resulting haloalkylhalosilane may be alkoxylated by reaction with a C | 2010-12-16 |
20100317886 | SYNTHESIS OF ISOTOPICALLY-LABELED FUNCTIONALIZED DIENES - All labeled carbons are derived ultimately from CO, as carbon-13 is separated from its lighter isotope by cyrogenic distillation of carbon monoxide (CO). Creation of stereospecific and site-specific compounds used for starting materials will address growing demands for labeled compounds, including isotopically-labeled functionalized dienes. Functionalized diene compounds can be used as precursors for the production of isotopically labeled pharmaceuticals, biomolecules, and natural products. | 2010-12-16 |
20100317887 | PROCESS FOR PREPARING (METH)ACRYLATES OF C10-ALCOHOL MIXTURES - Process for preparing (meth)acrylates of C | 2010-12-16 |
20100317888 | CARBONYLATION PROCESS WITH IN SITU REGENERATION OF MORDENITE CATALYST - A process for the carbonylation of dimethyl ether, dimethyl carbonate and/or methanol with carbon monoxide and hydrogen in the presence of a mordenite catalyst to produce at least one of acetic acid and methyl acetate in which process the mordenite catalyst is regenerated in-situ by contacting the catalyst with a regenerating gas comprising a molecular oxygen-containing gas and an inert diluent at a total pressure in the range 1 to 100 bar and wherein the partial pressure of the molecular oxygen-containing gas is such that the temperature of the catalyst is maintained within the range 225 to 325° C. | 2010-12-16 |
20100317889 | PROCESS FOR PREPARING ISOCYANATES - Process for preparing isocyanates by phosgenation of amines, wherein phosgene and amine are brought into contact in at least 2 mixing chambers connected in parallel. | 2010-12-16 |
20100317890 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same - Salts of L-carnitine and alkanoyl L-carnitines with phytic acid of general formula (I), and the process of preparing the same, wherein the mole ratio between the L-carnitine or its alkanoyl derivatives cation and phytic acid anion be within the range of 1:1 to 6:1, wherein: n=1-6; R | 2010-12-16 |
20100317891 | METHOD FOR THE PURIFICATION OF ORGANIC ACIDS - The invention relates to a method for the purification of worts containing optionally neutralised organic acids, which comprises the following steps: (a) removal of a portion at least of the divalent cations and optionally of a portion at least of the monovalent cations by passing the same on a cationic resin; and (b) nano-filtration of the resulting solution. | 2010-12-16 |
20100317892 | METHOD FOR PREPARING (METH)ACRYLIC ANHYDRIDE - The present invention relates to an improved method for preparing (meth)acrylic anhydride (A(M)A | 2010-12-16 |
20100317893 | METHOD FOR PRODUCING DIAMINODIPHENYL ALKANES - The invention relates to a method for producing diaminodiphenyl alkanes, wherein an aromatic amine, which can be substituted or unsubstituted, is reacted with a C1-C3 aldehyde in the presence of a heterogeneous catalyst, said catalyst being a mesoporous acidic ion exchanger based on a divinylbenzene/styrene copolymer and the catalyst having acid centers in a concentration of 2 to 6 eq/kg measured according to DIN 54 403 and the average pore diameter of the catalyst particles being 10 to 32 nm measured according to ASTM D 4222, and the content of polynuclear compounds in the reaction mixture being >10 and ≦15% by weight. | 2010-12-16 |
20100317894 | METHODS OF PRODUCING 1,3,5-TRIAMINO-2,4,6-TRINITROBENZENE - Methods of producing 1,3,5-triamino-2,4,6-trinitrobenzene (TATB), from alkoxy derivatives of phloroglucinol, such as 5-methoxyresorcinol, 3,5-dimethoxyphenol, or 1,3,5-trimethoxybenzene, are disclosed. The alkoxy derivatives may be exposed to and directly nitrated with a reaction mixture comprising a sulfuric acid solution and at least one nitrate salt. The nitrated alkoxy derivative of phloroglucinol may be alkoxylated and, thereafter, aminated to produce the TATB. | 2010-12-16 |
20100317895 | Process For Producing Cyclohexylbenzene - In a process for producing cyclohexylbenzene, hydrogen and a liquid feed comprising benzene are introduced into a reaction zone and are contacted in the reaction zone under hydroalkylation conditions to produce cyclohexylbenzene. An effluent stream comprising cyclohexylbenzene and unreacted benzene is removed from the reaction zone and is divided into at least first and second portions, wherein the mass ratio of the effluent stream first portion to the effluent stream second portion is at least 2:1. The effluent stream first portion is then cooled and the cooled effluent stream first portion is recycled to the reaction zone. | 2010-12-16 |
20100317896 | Process For Producing Sec-Butylbenzene - A process for producing sec-butylbenzene comprises feeding reactants comprising benzene and a C | 2010-12-16 |
20100317897 | Process for the Production of MIBC and /or IBHKI Plus TMN Using Copper-Based Catalysts - MIBC and/or a mixture of IBHK and TMN is produced from MIBK by a process comprising the step of contacting MIBK with hydrogen under condensation/hydrogenation/dehydration reactive conditions and in the presence of a catalytic amount of a Cu-based condensation/hydrogenation/dehydration catalyst. The relative amounts of MIBC and the mixture of IBHK and TMN are controlled by the reaction temperature, a lower temperature, e.g., 130 C, favoring MIBC alone, and a higher temperature, e.g., 200 C, favoring a mixture of MIBC and IBHK plus TMN. | 2010-12-16 |
20100317898 | NOVEL CATALYST FOR ALDOL CONDENSATION REACTIONS - Present invention presents catalytic systems for aldol condensation reactions. The efficiency of the catalytic systems of the present invention is comparable to those of the classical strong acid or strong base catalysts. | 2010-12-16 |
20100317899 | PROCESS FOR PRODUCING ALKYLBENZINE HYDROPEROXIDE - A process for producing an alkylbenzene hydroperoxide from an alkylbenzene solution containing 0.01 to 10 mmol/kg of phenols by subjecting the solution to oxidation with an oxygen-containing gas, including allowing a compound represented by formula (I) to be present in the alkylbenzene solution: | 2010-12-16 |
20100317900 | PROCESS FOR THE CONVERSION OF ALCOHOL (S) INTO ALCOHOL (S) WITH INCREASED CARBON-CHAIN - The present invention relates to a process for the conversion of alcohol (s) into alcohol (s) with increase carbon-chain. The present invention also relates to the production of an alcohol (s) from a carbonaceous feedstock; wherein the carbonaceous feedstock is first converted to synthesis gas which is then converted to alkyl carboxylate ester (s) which is then hydrogenated to produce alcohol (s). | 2010-12-16 |
20100317901 | NANO-METAL CATALYSTS FOR POLYOL HYDROGENOLYSIS - A catalyst composition can include: a support; a ruthenium catalyst (Ru) nanoparticle; and a linker linking the Ru nanoparticle to the support, wherein the linker is stable under hydrogenolysis conditions. In one aspect, the linker can include 3-aminopropyl trimethoxysilane (APTS) or derivatives thereof, such as those with amine functionality. In another aspect, the linker can include phosphotungstic acid (PTA) or other similar solid acid agents. In another aspect, the support can be selected from alumina, carbon, silica, a zeolite, TiO | 2010-12-16 |
20100317902 | SEPARATION OF DIOLS FROM A MIXTURE COMPRISING DIOLS AND POLYOLS - The present invention relates to a process for separation of diols from a mixture comprising diols and polyols, for example, from a reaction mixture obtained from hydrogenolysis of sorbitol. In particular, the present invention relates to separation of diols from the mixture using a combination of a wiped-film evaporator and a molecular evaporator to obtain diols in a high yield. | 2010-12-16 |
20100317903 | Integrated Process for Producing Diesel Fuel from Biological Material and Products, Uses and Equipment Relating to Said Process - The present invention relates to an integrated process for producing diesel fuel or fuel additive from biological material by producing paraffins by a Fischer-Tropsch reaction on one hand and by a catalytic hydrodeoxygenation of bio oils and fats on the other hand. The two hydrocarbon streams are combined and distilled together. The invention also relates to the use of lignocellulosic material, such as by-products of the wood-processing industry for producing diesel fuel and to a method for narrowing the chain length distribution of Fischer-Tropsch derived diesel fuel. The invention provides a high-quality middle distillate fraction from various biological sources and most preferably from by-products of the wood-processing industry. The invention also relates to equipment for producing fuel form biological material, which comprises a hydrodeoxygenation reactor ( | 2010-12-16 |
20100317904 | OLIGOMERIZATION OF ALPHA OLEFINS USING METALLOCENE-SSA CATALYST SYSTEMS AND USE OF THE RESULTANT POLYALPHAOLEFINS TO PREPARE LUBRICANT BLENDS - This disclosure provides for alpha olefin oligomers and polyalphaolefins (or PAOs) and methods of making the alpha olefin oligomers and PAOs. This disclosure encompasses metallocene-based alpha olefin oligomerization catalyst systems, including those that include at least one metallocene and an activator comprising a solid oxide chemically-treated with an electron withdrawing anion. The alpha olefin oligomers and PAOs prepared with these catalyst systems can have a high viscosity index combined with a low pour point, making them particularly useful in lubricant compositions and as viscosity modifiers. | 2010-12-16 |
20100317905 | Use of Methanol in the Production of Hydrogen and Fuel, Processes and Plants for the Production of Hydrogen and Fuel - The invention relates to the use of biomethanol from the pulp industry in the production of biohydrogen. The preferred biomethanol comprises purified biomethanol derived from black liquor. The invention also relates to a process for the production of biohydrogen from crude biomethanol recovered from black liquor and to a process for producing hydrocarbon biofuel using such biohydrogen as a hydrogen source. The invention further relates to a biofuel production facility for producing fuel from biohydrogen and biohydrocarbon, and to biofuel so produced. The invention makes it possible to produce a biofuel, wherein 100% of the raw material stems from non-fossil sources. | 2010-12-16 |
20100317906 | PROCESS AND CATALYST FOR SELECTIVE HYDROGENATION OF DIENES AND ACETYLENES - A process for the selective hydrogenation of dienes and acetylenes in a mixed hydrocarbon stream from a pyrolysis steam cracker in which a front end a one step acetylene hydrogenation is carried out using catalyst comprising (A) 1 to 30 wt. % based on the total weight of the catalyst of a catalytic component of nickel only or nickel and one or more elements selected from the group consisting of copper, rhenium, palladium, zinc, gold, silver, magnesium, molybdenum, calcium and bismuth deposited on (B) a support having the a BET surface area of from 1 to about 100 m | 2010-12-16 |
20100317907 | HIGH THROUGHPUT CLEAN FEED HYDROPROCESSING DEVELOPMENT METHOD - A method for determining a set of operating parameters for a commercial scale plug flow catalytic process and reactor system for hydroprocessing clean feedstocks in the presence of hydrogen, comprises the steps of: supplying a clean hydrocarbon feedstock to the inlet of a composite multistage series-connected laboratory scale plug flow reactor, the stages of said laboratory scale reactor each containing a catalyst suitable for the hydroprocessing of said feedstock; hydrocracking and isomerizing hydrocarbon molecules; sampling and measuring the concentration of reactants and catalytic process products and byproducts in the effluents of each of said reactor stages of said laboratory scale reactor for determining the nature of the catalytic reactions taking place in each such stage. | 2010-12-16 |
20100317908 | Integrated Dimethyl Ether Recovery From An Oxygenate-To-Olefins Process And Production Of Polypropylene - Provided is a method of producing polypropylene comprising contacting an oxygenate stream with a molecular sieve to form an olefin stream comprising propane, propylene and dimethylether; introducing the olefin stream into a propylene rectification tower possessing from less than 200 theoretical stages; withdrawing from the propylene rectification tower a bottom stream comprising dimethylether, a sidestream comprising propane, and an overhead stream comprising propane and propylene; introducing the overhead to a condenser to accumulate a propylene-rich stream; passing the propylene-rich stream to a splitter to produce (i) a first propylene stream that is introduced into a polypropylene reactor to contact a polyolefin catalyst, and (ii) a second propylene stream that is re-introduced into the rectification tower, the first and second propylene streams introduced at a desirable ratio; and recirculating the dimethylether stream to contact the molecular sieve. | 2010-12-16 |
20100317909 | CARBON NANOTUBE CATALYST FOR OLEFIN PRODUCTION - A method for producing olefins using a carbon nanotube catalyst is disclosed. Initially, a hydrocarbon feedstock is received. The hydrocarbon feedstock, the carbon nanotube catalyst, and steam are mixed in a thermal cracking reactor. The mixture is heated in the thermal cracking reactor to a particular temperature. The olefins are then separated from the mixture. The carbon nanotube catalyst can include carbon nanotubes coated with M1 | 2010-12-16 |
20100317910 | SAPO MOLECULAR SIEVE CATALYSTS AND THEIR PREPARATION AND USES - Novel silicoaluminophosphate molecular sieve compositions comprising SAPO-11 and SAPO-41 with at least about 5 wt % of in situ-produced amorphous portion. Such compositions can be uncalcined or calcined and novel processes for their preparation are described. These compositions, when loaded or impregnated with a catalytically active species such as a Group VIII noble metal are novel, and are excellent hydroisomerization catalysts. | 2010-12-16 |
20100317911 | METHOD FOR PREPARING CERAMIC WASTE FORM CONTAINING RADIOACTIVE RARE-EARTH AND TRANSURANIC OXIDE, AND CERAMIC WASTE FORM WITH ENHANCED DENSITY, HEAT-STABILITY, AND LEACH RESISTANCE PREPARED BY THE SAME - Disclosed herein is a method for preparing a ceramic waste form containing radioactive rare-earth and transuranic oxide, and the ceramic waste form with enhanced density, heat-stability, and leach resistance prepared by the same. | 2010-12-16 |
20100317912 | MAT FOR ABSORBING LIQUIDS - A fluid absorption mat is applied to a surgery/operating room floor during a medical procedure. The fluids are absorbed through an upper and lower non-woven, non-cellulose fibrous layer. The upper and lower layers dry while an intermediate layer made of a cloth or paper integrated with copolymers absorbs and retains fluids introduced into the absorption mat. Medical personnel are thereby exposed to minimal fluids and surgery room cleanup is more efficient. | 2010-12-16 |
20100317913 | IMPLANTABLE AUDITORY STIMULATION SYSTEM AND METHOD WITH OFFSET IMPLANTED MICROPHONES - An improved implantable auditory stimulation system includes two or more implanted microphones for transcutaneous detection of acoustic signals. Each of the implanted microphones provides an output signal. The microphone output signals may be combinatively utilized by an implanted processor to generate a signal for driving an implanted auditory stimulation device. The implanted microphones may be located at offset subcutaneous locations and/or may be provided with different design sensitivities, wherein combinative processing of the microphone output signals may yield an improved drive signal. In one embodiment, the microphone signal may be processed for beamforming and/or directionality purposes. | 2010-12-16 |
20100317914 | Optically Coupled Active Ossicular Replacement Prosthesis - An active ossicular replacement device is configured to couple the malleus to the stapes, and conduct sound through the vibratory structures of the ear in response to the transmitted electromagnetic energy. The electromagnetic energy may comprise light so as to decrease interference from sources of noise external to the user. The prosthetic device may comprise an assembly that can be implanted in the middle ear in a manner that simplifies surgery. The assembly may comprise a narrow cross-sectional profile such that the assembly can be positioned in the middle ear through an incision in the eardrum, for example without cutting bone that defines the shape of the ear canal or the shape of the middle ear. The prosthetic device can be sized to the user based on a measurement of the ear. | 2010-12-16 |
20100317915 | FOCUSING BOARD ASSEMBLY FOR MEDICAL IMAGING EQUIPMENT - A focusing board assembly for a medical imaging equipment gives a comfortable feeling mentally or physically by visually getting rid of an oppressive feeling arisen when a patient is in a tunnel-like enclosed space such as MRI or CT for his/her medical examination. | 2010-12-16 |
20100317916 | Method for relative quantitation of chromosomal DNA copy number in single or few cells - The present invention is directed to methods for determining the presence or absence of a genetic defect in an IVF embryo prior to transfer comprising performing real-time PCR and 2 | 2010-12-16 |
20100317917 | FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES - The invention relates to a method for enhancing fertilization. Fertilization enhancement is achieved by effectively delivering bioactive molecules with a lipid anchor, (GPI-linked proteins), in the presence of a lipid carrier to the surface of epididymal or ejaculated sperm. The enhanced sperm are used for fertilization via in vitro fertilization or intrauterine insemination | 2010-12-16 |
20100317918 | Septum attached ventricular support - A method and device are disclosed for treating congestive heart disease. The material of the device is secured to the heart proximate the septal wall. The material covering the ventricles may or may not have the same tension and or compliance. The device can be constructed as a unitary “jacket” that is slipped over the apex of the heart. Alternately, the device implanted as one, two or more separate components. In one embodiment, the material covers both the left and right ventricles. In another embodiment, the material covers only one ventricle. The device may include at least one adjustment mechanism configured to adjust the tension of the material. Preferably, the device includes a first adjustment mechanism configured to adjust a tension of the material covering the right ventricle and a second adjustment mechanism configured to adjust the tension of the material covering the left ventricle such that the tension of the material covering the left ventricle can be different than the tension of the material covering the right ventricle. | 2010-12-16 |
20100317919 | SPECTRAL ENDOSCOPE AND ITS WAVELENGTH CALIBRATION METHOD - When using a spectral endoscope, the spectral characteristic can be precisely set to be suitable for use conditions. There is provided a spectral endoscope ( | 2010-12-16 |
20100317920 | ENDOSCOPE APPARATUS AND PROGRAM - An endoscope apparatus includes: an imaging portion imaging a subject to generate image data; a designation portion designating a position in an image based on the image data; an image processing portion processing the image data such that an enlarged image obtained by enlarging an image in a second region including the designated position overlaps a first region including the designated position designated by the designation portion; a display portion displaying the enlarged image and the image of the subject based on the image data processed by the image processing portion and displays a cursor at the designated position on the enlarged image; and a measurement processing portion performing measurement on the basis of a measurement position indicated by the cursor by using the image data generated by the imaging portion. The enlarged image displayed on the display portion moves according to movement of the cursor. | 2010-12-16 |
20100317921 | BALLOON EXPANDABLE INTRAVASCULAR BASKET CATHETER - The invention provides balloon-expandable intravascular basket-style catheters optimized for efficient interrogation of blood vessel walls. Related diagnostic systems and methods are also provided. | 2010-12-16 |
20100317922 | ENDOSCOPE SYSTEM - An object is to provide an endoscope system that is capable of cooling photoelectric conversion devices provided in an inserted portion while suppressing an increase in an outer diameter of the inserted portion. An endoscope system employed includes a long, thin inserted portion; photoelectric conversion devices that are mounted at a distal end of the inserted portion; a fluid-feed channel that is provided in the inserted portion and that has a fluid-feed port which opens at the distal end of the inserted portion; a radiator that is connected to an intermediate position of the fluid-feed channel and that is provided in a manner enabling heat exchange with the photoelectric conversion devices; and a fluid-supply-direction switching portion that switches a supply direction of cooling fluid fed by the fluid-feed channel to the fluid-feed port side or to the radiator side. | 2010-12-16 |
20100317923 | ENDOSCOPE SYSTEM, ENDOSCOPE, AND DRIVING METHOD - An endoscope includes an elongated tube. An objective lens system is disposed in the elongated tube, for passing image light from an object. A fiber optic image guide includes plural optical fibers bundled together, has a distal tip, is inserted through the elongated tube, for transmitting the image light focused on the distal tip by the objective lens system in a proximal direction. A displacing device displaces the distal tip laterally and periodically upon receiving entry of the image light being focused by use of a piezoelectric actuator positioned outside the distal tip. An image sensor creates images in plural set positions of the distal tip. First to fourth images among the plural images created consecutively are combined to form a first synthesized image. Then second to fifth images among the plural images without use of the first image are combined to form a second synthesized image. | 2010-12-16 |
20100317924 | DIGITAL IMAGE DATA COLLECTION APPARATUS SYSTEM AND METHOD - To provide additional capabilities when utilizing an otoscope apparatus, an attachment device is provided for digitally capturing medical data for ears, nose and throat patients. The device is implemented as an attachment to an otoscope, which replaces the wide angle viewing lens of the instrument head, for the purpose of digitally capturing diagnostic images and data. In practice this may typically include images of the tympanic membrane, ear canal, tharynx and nasal cavity. A method and system is utilized that assigns a unique identifier to each image, specific to each patient, based on predetermined criteria as well as the date and time. The attachment device is provided with the capability to magnify and/or reduce the image dimension via a focusable lens of the apparatus, while an internal processor displays and stores suitable images. Additionally, the device includes the ability to record notes, observations and comments via a dictation feature. The displayed and stored digital images, records, dictated notes and any related data are then categorized and retained by the system while being readily accessible for download or transmission, via a USB connection, wireless connection, network connection or portable memory card. | 2010-12-16 |
20100317925 | SUCTION-ASSISTED TISSUE STABILIZERS - Suction assisted tissue stabilizers that include portions that deflect when force is applied thereto and return to their initial shape when the force is removed. | 2010-12-16 |
20100317926 | Suction-Based Tissue Manipulator - A surgical assembly including a flexible shell that defines a flexible sheet-like structure with a major top wall opposite a major bottom wall. The top wall is impermeable to air flow therethrough and has a first set of holes that allow for air flow therethrough. The bottom wall is impermeable to air flow therethrough and has a second set of holes that allow for air flow therethrough. A first fluid path supplies a source of suction to the first set of holes in a manner that is independent to suction supplied the second set of holes. A second fluid path supplies a source of suction to the second set of holes in a manner that is independent to suction supplied to the first set of holes. The supply of suction to the first set of holes is used to engage and hold tissue adjacent the top wall by suction forces applied through the first set of holes. The supply of suction to the second set of holes is used to engage and hold tissue adjacent the bottom wall by suction forces applied through the second set of holes. The tissue that is engaged adjacent the top wall is sealably disposed about the first set of holes, and tissue that is engaged adjacent the bottom wall is sealably disposed about the second set of holes. | 2010-12-16 |
20100317927 | HANDS FREE USE OF A BALFOUR BLADE - A self retaining adaptor enables hands free use of a balfour retractor blade. An elongated element includes a proximal end and a distal end. The elongated element includes an intermediate portion extending from the proximal end to the distal end. The intermediate portion has a predetermined width with an elongated slot being formed therein. The elongated slot includes a predetermined number of enlarged openings formed at predetermined intervals along the length of the slot. The enlarged openings enable the insertion of a wing-nut connection for attaching a member to the elongated element. | 2010-12-16 |